Recent Quotes (30 days)

You have no recent quotes
chg | %

Response Biomedical Corp.  

(Public, TSE:RBM)   Watch this stock  
Find more results for RBM
1.43
+0.05 (3.62%)
Aug 27 - Close
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 1.40 - 1.43
52 week 1.26 - 3.10
Open 1.40
Vol / Avg. 13,883.00/1,846.00
Mkt cap 11.36M
P/E 3.80
Div/yield     -
EPS 0.38
Shares 7.94M
Beta -3.84
Inst. own     -
Aug 11, 2014
Q2 2014 Response Biomedical Corp Earnings Call
Aug 11, 2014
Q2 2014 Response Biomedical Corp Earnings Release
  

Key stats and ratios

Q1 (Mar '14) 2013
Net profit margin -59.52% -52.02%
Operating margin -44.90% -27.79%
EBITD margin - -19.18%
Return on average assets -42.00% -42.01%
Return on average equity - -
Employees 65 -
CDP Score - -

Address

1781 - 75TH AVENUE W.
VANCOUVER, BC V6P6P2
Canada
+1-604-4566010 (Phone)
+1-604-4566066 (Fax)

Website links

Description

Response Biomedical Corporation (Response) develops, manufactures and markets rapid on-site diagnostic tests for use with its RAMP platform for clinical and environmental applications. RAMP represents a paradigm in diagnostics that provides sensitivity and reliable information in minutes. It is ideally suited to both point of care testing and laboratory use. The RAMP system is a platform technology that combines a sensitive, portable fluorescence detection system with simple lateral flow immunoassays. RAMP maintains key positive attributes of lateral flow immunoassays - simplicity, specificity, reliability and rapid results - but includes a method to overcome the performance limitations of early generation immunoassays that suffer from relatively poor sensitivity and precision.

Officers and directors

Peter A. Thompson M.D. Executive Chairman of the Board
Age: 53
Jeffrey L. Purvin Chief Executive Officer, Director
Age: 61
William J. Adams Chief Financial Officer, Corporate Secretary
Age: 51
Barbara Kinnaird Kinnaird Steen Ph.D. Vice President of Research and Development
Age: 46
Zheng Wang General Manager, Asia Pacific
Jonathan Wang Ph.D. Director
Age: 45
Anthony F. Holler M.D. Independent Director
Age: 61
Joseph D. Keegan Ph.D. Independent Director
Clinton H. Severson Independent Director
Age: 64
Lewis J. Shuster Independent Director
Age: 58